EHR+Wearables for Stroke, Seasonal Oncology Bias & Retatrutide Signals
A wearable alert turned a vague stroke risk into action for one patient. From founders building governance-first pipelines to real-world retatrutide safety signals, this story-driven post shows how EHR and wearable fusion and seasonal confounding fixes keep patients hopeful.
Robert Maxwell
Sep 18, 2025
retatrutide trials
Metastatic breast cancer
stroke registry analytics
PCOS real-world data
